{"disease":{"id":"high-grade-squamous-intraepithelial-lesion","name":"high grade squamous intraepithelial lesion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02135419","title":"Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4446,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT05282745","title":"A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT04190472","title":"Intraoperative HPV Testing Evaluation","phase":"","overall_status":"UNKNOWN","enrollment_count":1553,"lead_sponsor_name":"Hospital Universitari Vall d'Hebron Research Institute","has_results":false},{"nct_id":"NCT06002126","title":"Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1002,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05210348","title":"Clinical Evaluation of Detection of High Risk HPV in Urine","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05283239","title":"Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05745597","title":"Prognostic Study of HPV Virus Integration in Women With HSIL","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT05531799","title":"Anal HSIL Screening Algorithm","phase":"NA","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Institute of HIV Research and Innovation Foundation, Thailand","has_results":false},{"nct_id":"NCT06325592","title":"Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patients With Cervical HSIL","phase":"","overall_status":"COMPLETED","enrollment_count":826,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT02140021","title":"Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":409,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02836522","title":"Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)","phase":"","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03961191","title":"DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT04177641","title":"Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Muğla Sıtkı Koçman University","has_results":false},{"nct_id":"NCT05282095","title":"Effect of HPV Integration on Prognosis of Young Women With CIN2 in China","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Fujian Maternity and Child Health Hospital","has_results":false},{"nct_id":"NCT03960879","title":"DNA Methylation for Screening Uterine Cervical Lesions","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06651957","title":"Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)","phase":"","overall_status":"COMPLETED","enrollment_count":217,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03721978","title":"REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT03185013","title":"REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT03051516","title":"HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":188,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT01928225","title":"Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University of Witwatersrand, South Africa","has_results":true},{"nct_id":"NCT04563754","title":"The Effectiveness of High Resolution Microendoscopy for People Living With HIV","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Baylor College of Medicine","has_results":true},{"nct_id":"NCT07175662","title":"Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Newish Biotech (Wuxi) Co., Ltd.","has_results":false},{"nct_id":"NCT04115787","title":"Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN","phase":"","overall_status":"UNKNOWN","enrollment_count":104,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT05060640","title":"ANAL PRECANCEROUS LESIONS IN HIGH-RISK PATIENTS.","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"University Fernando Pessoa","has_results":false},{"nct_id":"NCT03920800","title":"Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Catherine Vanpachterbeke","has_results":false},{"nct_id":"NCT06356012","title":"Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Barretos Cancer Hospital","has_results":false},{"nct_id":"NCT02059499","title":"Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT06949800","title":"CASCADE 2002: PROTECT Study, \"PRObiotics to TrEat Anal preCancer Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04633330","title":"Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT03202992","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT06206564","title":"Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Frantz Viral Therapeutics, LLC","has_results":false},{"nct_id":"NCT03180684","title":"Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT05858021","title":"COrSIcA: Disease Measurement","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"David Finch","has_results":false},{"nct_id":"NCT05555862","title":"Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Frantz Viral Therapeutics, LLC","has_results":false},{"nct_id":"NCT05104099","title":"Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Institut de Cancérologie de Lorraine","has_results":false},{"nct_id":"NCT03239223","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03267680","title":"IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT07047989","title":"NWRD09 for HPV-16 Related Cervical HSIL","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Newish Biotech (Wuxi) Co., Ltd.","has_results":false},{"nct_id":"NCT06276101","title":"NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"Newish Technology (Beijing) Co., Ltd.","has_results":false},{"nct_id":"NCT03697226","title":"Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03677960","title":"Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Antiva Biosciences","has_results":false},{"nct_id":"NCT03197025","title":"Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":42},"guidelines":[],"source":"Drug Landscape verified database"}